H.R. 1143
119th Congress
Medicare IVIG Access Enhancement Act of 2025
2
Cosponsors
4
Actions
0
Amendments
0
Committees
—
Since introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
7 février 2025·1 year ago
Summary
Introduced in House · Updated 28 avril 2025
Medicare IVIG Access Enhancement Act of 2025
This bill provides for Medicare coverage of in-home administration of intravenous immune globulin to treat chronic inflammatory demyelinating polyneuropathy (CIDP) or multifocal motor neuropathy. (CIDP is an autoimmune condition that causes symptoms such as muscle weakness and numbness; multifocal motor neuropathy is a variant of CIDP that only causes asymmetric muscle weakness.)
Timeline
4 actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
7 février 2025 · IntroReferral
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
7 février 2025 · IntroReferral
Introduced in House
7 février 2025 · IntroReferral
Introduced in House
7 février 2025 · IntroReferral
Sponsorship
2 cosponsors
Sponsor
Republican:Rep. Smith, Adrian [R-NE-3]NECosponsors
- Democrat2100%
- Democrat:Rep. Vindman, Eugene Simon [D-VA-7]VA
- Democrat:Rep. Garamendi, John [D-CA-8]CA
Classification
Policy area
HealthLegislative subjects
Cosponsor momentum
Cumulative over time
Cosponsors grew from 1 on 7 février 2025 to 2 on 4 novembre 2025.
Track Medicare IVIG Access Enhancement Act of 2025 as it moves through Congress
Get alerts on votes, amendments, and stock-market impact